This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Comprehensive Look at Vascular Access

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Christie Medical Holdings, Inc.
ClinicalTrials.gov Identifier:
NCT01638065
First received: July 9, 2012
Last updated: January 30, 2014
Last verified: January 2014
  Purpose
The objective of this study is to show VeinViewer® Vision is an effective vein visualization device for peripheral vascular access, pre-, during, and post access.

Condition
Vascular Access

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: A Comprehensive Look at Vascular Access: Utilizing a Near Infrared Vein Visualization Device For Vascular Access Planning, Attempts, and Post Access

Further study details as provided by Christie Medical Holdings, Inc.:

Primary Outcome Measures:
  • The primary endpoint will be total number of attempts for successful cannulation. [ Time Frame: 1 day ]

Secondary Outcome Measures:
  • Amount of time for successful venous access [ Time Frame: 1 day ]

Enrollment: 196
Study Start Date: May 2012
Study Completion Date: July 2013
Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
Standard
Standard IV Access without device
VeinViewer
IV access with VeinViewer device

  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients at a medical facility requiring IV access.
Criteria

Inclusion Criteria:

  • Requires peripheral venous access
  • Intact skin on areas of assessment
  • Patient and/or parent or legal guardian is able to understand consent

Exclusion Criteria:

  • No Intact skin
  • Patient is under anesthesia during peripheral venous access
  • Patient is not a suitable candidate, as determined by the discretion of the investigator
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01638065

Locations
United States, California
LA County Hospital
Los Angeles, California, United States, 90033
United States, Illinois
Good Samaritan Hospital
Downers Grove, Illinois, United States, 60515
Sponsors and Collaborators
Christie Medical Holdings, Inc.
  More Information

Responsible Party: Christie Medical Holdings, Inc.
ClinicalTrials.gov Identifier: NCT01638065     History of Changes
Other Study ID Numbers: CP1011
Study First Received: July 9, 2012
Last Updated: January 30, 2014

Keywords provided by Christie Medical Holdings, Inc.:
vein identification
vascular access

ClinicalTrials.gov processed this record on August 18, 2017